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ABSTRACT
Emergence of the bi-subunit topoisomerase I in the
kinetoplastid family (Trypanosoma and Leishmania)
has brought a new twist in topoisomerase research
related to evolution, functional conservation and
preferential sensitivities to the specific inhibitors of
typeIBtopoisomerasefamily.Inthepresentstudy,we
describe that naturally occurring flavones baicalein,
luteolin and quercetin are potent inhibitors of the
recombinant Leishmania donovani topoisomerase I.
These compounds bind to the free enzyme and also
intercalate into the DNA at a very high concentration
(300 mM) without binding to the minor grove. Here,
we show that inhibition of topoisomerase I by these
flavones is due to stabilization of topoisomerase I–
DNA cleavage complexes, which subsequently
inhibit the religation step. Their ability to stabilize
the covalent topoisomerase I–DNA complex in vitro
and in living cells is similar to that of the known
topoisomerase I inhibitor camptothecin (CPT). How-
ever,incontrasttoCPT,baicaleinandluteolinfailedto
inhibit the religation step when the drugs were added
to pre-formed enzyme substrate binary complex. This
differential mechanism to induce the stabilization of
cleavable complex with topoisomerase I and DNA by
these selected flavones and CPT led us to investigate
the effect of baicalein and luteolin on CPT-resistant
mutant enzyme LdTOP1D39LS lacking 1–39 amino
acids of the large subunit [B. B. Das, N. Sen,
S. B. Dasgupta, A. Ganguly and H. K. Majumder (2005)
J. Biol. Chem. 280, 16335–16344]. Baicalein and luteolin
stabilize duplex oligonucleotide cleavage with
LdTOP1D39LS. This observation was further suppo-
rted by the stabilization of in vivo cleavable complex
by baicalein and luteolin with highly CPT-resistant
L.donovani strain. Taken together, our data suggest
that the interacting amino acid residues of topoisome-
rase I may be partially overlapping or different for
flavones and CPT. This study illuminates new proper-
ties of the flavones and provide additional insights into
the ligand binding properties of L.donovani topoiso-
merase I.
INTRODUCTION
DNA topoisomerases are ubiquitous enzymes that govern the
topology of DNA inside cells and are involved in vital cellular
processes (1). All eukaryotic type IB topoisomerases are
monomers and consist of four domains (2). Cleavage occurs
by a trans-esteriﬁcation reaction involving nucleophilic attack
by an active tyrosine (Tyr
723 in human Topo I) on a DNA
phosphodiester bond resulting in the formation of a covalent
DNA 30-phosphotyrosyl linkage. In the religation phase a
similar trans-esteriﬁcation reaction involves attack by the
free DNA 50-hydroxyl that releases the enzyme from the
DNA (2,3).
In contrast, Leishmania donovani topoisomerase I is an
unusual bi-subunit enzyme where the core DNA binding
domain and the catalytic domain harboring the consensus
SKXXY motif lie in separate subunits. The two subunits
are synthesized by two different genes, which associate
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doi:10.1093/nar/gkj502with each other through protein–protein interaction to form an
active heterodimeric topoisomerase I within the parasite. This
unusual structure of DNA topoisomerase I in the kinetoplastid
family may provide a missing link in the evolution of type IB
enzyme (4–6).
Camptothecin (CPT), an important class of antitumor agent
(7), represents the best characterized topoisomerase IB
inhibitor. CPT binds reversibly to the covalent intermediate
DNA-enzyme, stabilizing the cleavable complex and reducing
the rate of religation (8,9). The stalled topoisomerase I collides
with the progression of the replication fork producing lethal
double-strand DNA breaks and causing cell death (10).
Recently, important contribution toward the understanding
of the interaction of CPT with topoisomerase I and DNA
has been provided by the crystal 3D structure of the ternary
complex between human topoisomerase I covalently linked to
DNA and the CPT derivative topotecan (11). The structure
shows that the drug intercalates into DNA duplex and moves
the 50-hydroxyl end of the DNA away from the scissile
phosphate. This misalignment of the two ends probably
slows the religation reaction (11).
We have previously demonstrated the in vitro reconstitution
of bi-subunit topoisomerase I (LdTOP1LS) of L.donovani (5).
Our recent ﬁndings reveal that 1–39 amino acid residues of the
large subunit have a modulating role in non-covalent interac-
tion with DNA and sensitivity to CPT, while the residues
within 40 and 99 amino acid region of LdTOP1L appear to
be important in relation to interaction with LdTOP1S (6). CPT
enhances the formation of ‘cleavable complex’ at low salt (5).
It induces cellular dysfunction in L.donovani promastigotes
and amastigotes with features that are well characterized by
several cytoplasmic and nuclear events of apoptosis (12,13).
In Trypanosoma brucei, Trypanosoma cruzi and L.donovani,
CPT promotes protein–DNA complex formation with nuclear
as well as kinetoplast DNA (14). Recently, highly CPT-
resistant L.donovani strain (LdRCPT.160) was developed
by stepwise exposure to CPT that induces point mutations
(Gly 185 Arg and Asp325 Glu) in the large subunit
(LdTOP1L) of the bi-subunit topoisomerase I (15).
Flavonoids are a diverse group of naturally occurring
polyphenolic compounds with profound pharmacological
properties (16). They are reported to have anti-viral (17),
anti-cancer (18) and anti-parasitic (19) activities. Among
naturally occurring ﬂavonoids, quercetin and luteolin are
most widely studied in vitro and in vivo. (19). Baicalein
(5, 6, 7 trihydroxy ﬂavone), another important ﬂavonoid,
has multiple biological activities (20–23) and is also reported
as topoisomerase II inhibitor (22).
We have previously established that luteolin and quercetin
inhibit topoisomerase II and induce apoptotic death of
L.donovani promastigotes (19). While much attention has
been placed on the study of topoisomerase II inhibition by
polyphenolic compounds, less attention has centered on
topoisomerase I inhibition. Thus, further studies are needed
to understand the molecular mechanism of interaction of the
selected ﬂavonoids with DNA topoisomerase I.
In the present study, we have dissected the mechanism of
action of ﬂavones and CPT. Though the selected ﬂavones,
baicalein, luteolin and quercetin stabilize topoisomerase
I–DNA cleavable complex like CPT, the interaction of the
ﬂavones and CPT appears to be different during the formation
of the cleavable complex. This interpretation is well supported
by our study with CPT-resistant mutant enzyme and
CPT-resistant L.donovani promastigotes cells. Thus, our
studies provide insights into the ﬂavone-mediated inhibition
of L.donovani topoisomerase I.
MATERIALS AND METHODS
Materials
Baicalein (5,6,7 trihydroxyﬂavone) C15H10O5, melting point
260 C, used in the study is isolated from the stem-bark
of Oroxylum indicum. The structure of the compound was
ascertained by spectroscopic analysis and by super imposable
infrared (IR) spectra and undepressed mixed melting point
with authentic samples (19). Dihydrobetulinic acid (DHBA)
was puriﬁed as described previously (24). CPT, luteolin and
quercetin were purchased from Sigma Chemicals (St Louis,
MO). The drugs were dissolved in 100% dimethyl sulfoxide
(DMSO) at 20 mM concentration and stored at  20 C.
Purification of recombinant proteins and reconstitution
of topoisomerase I activity
Escherichia coli BL21(DE3)pLysS cells harboring
pET16bLdTOP1L, pET16bLdTOP1D39L and pET16bLd-
TOP1S described previously (6) were separately induced at
OD600 ¼ 0.6 with 0.5 mM Isopropyl-b-D-thiogalactopyrano-
side at 22 C for 12 h. Cells harvested from 1 L of culture were
separately lysed by lysozyme/sonication and the proteins were
puriﬁed through Ni
+2-NTA agarose column (Qiagen) followed
by phosphocellulose column (P11 cellulose, Whatman) as
described previously (14). Finally, the puriﬁed proteins
LdTOP1L, LdTOP1D39L and LdTOP1S were stored at
 70 C. E.coli BL21 (DE3) cells harboring pGEX-GST-
LdTOP1S were over-expressed, solubilized and puriﬁed
through glutathione S-transferase (GST)–Sepharose column
as described previously (14). The concentrations of puriﬁed
proteins were quantiﬁed by Bradford reaction using a Bio-Rad
Protein Estimation Kit according to the manufacturer’s
protocol.
Puriﬁed LdTOP1L or LdTOP1D39L were mixed with
puriﬁed LdTOP1S separately at a molar ratio of 1:1 and at
a total protein concentration of 0.5 mg/ml in reconstitution
buffer (50 mM potassium phosphate, pH 7.5, 0.5 mM DTT,
1 mM EDTA, 0.1 mM phenylmethlysulfonyl ﬂuoride and
10% glycerol). The mixtures were dialyzed overnight at
4 C and the dialyzed fractions were used for plasmid
relaxation activity (5,6).
Plasmid relaxation assay
The type I DNA topoisomerase was assayed by decreased
mobility of the relaxed isomers of supercoiled pBluescript
(SK
+) DNA in an agarose gel. Relaxation assay was carried
out as described previously (5,6) with LdTOP1LS, and
LdTOP1D39LS serially diluted in the relaxation buffer
(25 mMTris–HCl, pH 7.5, 5% glycerol, 0.5 mM DTT,
10 mM MgCl2, 2.5 mM EDTA and 150 mg/ml BSA), super-
coiled pBluscript (SK
+) DNA and 50 mM KCl. The amount of
supercoiled monomer DNA band ﬂorescence after ethidium
bromide (EtBr) (0.5 mg/ml) staining was quantitated by using
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Analysis of duplex oligonucleotides cleavage assay
The 25mer duplex of oligonucleotide 1 (50-GAAAAAA-
GACTT#AGAAAAATTTTTA-30) and oligonucleotide 2
(50-TAAAAATTTTTCTAAGTCTTTTTTC-30) containing a
topoisomerase I binding motif was labeled and annealed as
described previously (6). Cleavage was carried out using
20-fold molar excess of the wild-type (LdTOP1LS) and
mutant enzymes (LdTOP1D39LS) over duplex 25mer DNA
(enzymes, 0.2 mM; DNA, 10 nM). The reactions were carried
out in standard assay mixture containing 10 mM Tris–HCl,
pH 7.5, 10 mM MgCl2, 0.5 mM EDTA and 50 mM KCl in
the presence or absence of drugs (60 mM) at 37 C for 30 min
or at indicated time periods. All the reactions were stopped
by addition of SDS to a ﬁnal concentration of 2% (w/v).
Samples were precipitated with ethanol, digested with 5 ml
of 1 mg/ml trypsin and analyzed by 12% denaturing poly-
acrylamide gel followed by autoradiography. The amount
of strand cleavage in the presence of drugs for the wild-type
and mutant enzymes were determined by ﬁlm densitometry as
described previously (6).
Fluorescence binding assay
Fluorescence titrations were performed using a F-3010
spectroﬂuorometer (HITACHI/JAPAN). The intrinsic binding
of the ﬂavones to DNA and the enzyme (LdTOP1LS) was
performed in different experiments. The ﬂuorescence
measurements were performed separately at an excitation
wavelength of 364 nm for baicalein, 380 nm for luteolin
and 370 nm for quercetin and emission range of 450–600 nm.
Excitation and emission slit widths were 10 and 15 nm,
respectively.Background emission (<2%) was corrected by sub-
traction of spectra of blank buffer and enzyme from DNA plus
sample buffer and ﬂavones plus enzyme samples respectively.
Spectral titration was performed with ﬂavones at 25 Ci n
ﬂuorescence buffer (20 mM Tris–HCl, pH 7.5, 50 mM NaCl
a n d1 0m MM g C l 2). DNA or topoisomerase I was added in
increasing concentrations as indicated in the legend. All the
assays were performed in duplicate; titration points are corrected
as described above; and binding constants for ﬂavones-
LdTOP1LS interaction were determined according to following
equation (25):
1=DF ¼ 1=DFmax þð 1=Ka:StÞð1=DFmaxÞ 1
where DF ¼ Fx   Fo, Fx and Fo representing the ﬂorescence
intensity of the selected ﬂavones in the presence or absence of
the added total LdTOP1LS (St), respectively. DFmax is the
maximum change in the ﬂuorescence intensity. The intercept
of the plots on the 1/F axis measures the 1/Fmax, while the
slope gives the estimation of Ka. Dissociation constant
Kd ¼ 1/Ka.
Analysis of flavones–DNA intercalation
The intercalation between baicalein, luteolin and quercetin
was assessed by two independent techniques. First, the ability
of the drug to intercalate into plasmid DNA was determined
by topoisomerase I unwinding assay (26,27). Assays were
performed with 50 fmol of pBluscript (SK
+) DNA in the
presence or absence of baicalein, luteolin, quercetin,
m-AMSA and etoposide in a 50 ml of reaction mixture as
described above. Relaxed DNA was prepared by treatment
of the supercoiled plasmid DNA with excess of topoisomerase
I, followed by proteinase K digestion at 37 C, phenol/
chloroform extraction and ethanol precipitation. After incubation
at 37 C for 15 min, reactions were terminated by the addition of
prewarmed stop solution [5% SDS, 15% (w/v) Ficoll and 0.25%
Bromophenol Blue] and electrophoresed on to 1% agarose gel as
described above. The DNA band was stained with 0.5 mg/ml of
EtBr and visualized by UV light as described above.
Second, an ethidium-displacement ﬂuorescence assay (28)
was employed to determine whether the selected ﬂavone binds
in the minor groove of DNA. Fluorescence emission spectra
(lmax ¼590 nm, excitation wavelength 510 nm) were obtained
at 25 C. The assays contained 1 mM EtBr, 0–300 mM of the
selected ﬂavones and 5 nM calf thymus (CT) DNA in 2 ml of
ﬂuorescence buffer.
Single turnover cleavage and religation experiment
A 14mer (50-GAAAAAAGACTT#AG-30) oligonucleotide
containing topoisomerase IB speciﬁc cleavage site was
50-
32P-end labeled and annealed to 25mer (30-
CTTTTTTCTGAATCTTTTTAAAAAT p-50) oligonucleo-
tide asdescribedpreviously(6). Thesuicidalcleavage reaction
was carried out with 5 nM of DNA substrate and 0.15 mMo f
enzyme (LdTOP1LS) in 20 ml reaction mixture under standard
assay condition (10 mM Tris–HCl, pH 7.5, 10 mM MgCl2,
0.5mMEDTAand50mMKCl)at23 Cfor4hinthepresence
or absence of drugs as described previously (6).
For religation experiments, covalent complexes generated
by incubating suicide DNA substrate with LdTOP1LS in
the presence or absence of drugs were transferred to 37 C
and pre-incubated for 2 min. Religation was initiated by the
addition of 300-fold molar excess of the 11mer religation
acceptor oligonucleotides (50-OH-AGAAAAATTTT-30)i n
the same reaction mixture and incubated for indicated time
periods. Finally, all the reactions were stopped by adding SDS,
andDNAsweresubsequentlyprecipitatedbyethanol.Samples
were digested with 5 ml of 1mg/ml trypsin, electrophoresed in
12% denaturing polyacrylamide gel and autoradiographed as
described previously (6).
Parasite, culture condition and development of
CPT-resistant L.donovani strain
L.donovani AG83 promastigotes were grown at 22 C in Rays
modiﬁed media as described previously (19,24) and M199
liquid media supplemented with 10% fetal calf serum (FCS).
A highly resistant L.donovani strain Ld160CPT
R was
selected by stepwise exposure to CPT (5, 10, 40, 80, 100 and
160 mM) as described previously (15). The CPT-resistant strain
reached a resistance level of 32-fold over the wild-type
L.donovani AG83 strain.
Cytotoxicity of the drugs was estimated by microscopic
counting of viable parasites by trypan blue exclusion method
after treatment of L.donovani promastigotes with drugs as
described previously (24).
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Leishmania promastigotes
DNA–protein complexes can be trapped within cells and
quantiﬁed by the KCl-SDS coprecipitation assay (29).
Exponentially growing L.donovani promastigotes (5 · 10
6
cells/ml) or CPT-resistant L.donovani strain Ld160CPT
R
wereradiolabeledbyadding[methyl-
3H]thymidine(Amersham)
into the medium to a ﬁnal concentration of 5 mCi/ml for 24 h at
22 C. Cells werethen pelleted,washedtwiceandresuspendedin
fresh M199 liquid media supplemented with 10% FCS for 3 h.
Cells were then exposed to various concentrations of baicalein,
luteolin, quercetin, CPT and DHBA at 22 C for indicated time
periods. Finally, the cells were lysed in 200 mlo fS D S -
containing solution [1.25% SDS, 5 mM EDTA (pH 8) and
CT DNA (0.4 mg/ml)] prewarmed at 65 C. The lysates were
transferred into 1.5 ml microfuge tubes containing 250 ml
of325mMKCl.Aftervigorousmixing,thesampleswerecooled
on ice for 10 min and centrifuged. The pellets were resuspended
in 500 ml of wash solution [10 mM Tris–HCL, pH 8, 100 mM
KCl, 1 mM EDTA and CT DNA (0.1 mg/ml)] and warmed at
65 C for 10 min with occasional shaking. The suspensions were
cooled on ice for 10 min and re-centrifuged. The pellets were
washed as above, mixed with 4 ml of scintillation liquiﬂuor
(Spectrochem, India) and radioactivity was determined in the
liquid scintillation counter.
RESULTS
Effect of flavones on the DNA relaxation activity of
reconstituted LdTOP1LS
Puriﬁcation of recombinant subunits (LdTOP1L and
LdTOP1S) and reconstitution ofenzyme(LdTOP1LS) activity
was examined by plasmid DNA relaxation assay as described
previously (5,6). We have shown earlier that the
parasite-reconstituted enzyme is active at low salt and the
optimum activity is at 50 mM KCl and 10 mM Mg
+2
concentrations (5). Thus, the subsequent relaxation experi-
ments were performed at the above-mentioned conditions.
Toinvestigate theeffect oftheselectedﬂavones(Figure1A)
oninvitro plasmidDNArelaxationactivityoftherecombinant
Leishmania topoisomerase I, relaxation experiments were
performed in a standard assay mixture where the plasmid
DNA and the enzyme (LdTOP1LS) were mixed at a molar
ratio of 3:1. Luteolin, quercetin and baicalein inhibit
LdTOP1LS relaxation activity compared with the enzyme
control (Figure 1B). Under same condition LdTOP1LS is
also inhibited by CPT (Figure 1B) as observed previously
(6). Thus, in the light of our experiment ﬂavones are also
potential inhibitors of topoisomerase I like CPT.
The selected ﬂavones (baicalein, luteolin and quercetin)
by themselves do not relax DNA. To test this, supercoiled
pBluescript (SK
+) DNA was incubated separately with 50 mM
each of the ﬂavones. No relaxation and no apparent DNA
conformational changes took place because of the unwinding
of DNA (data not shown).
To investigate the interaction of the selected ﬂavones with
the enzyme in the relaxation experiment, LdTOP1LS was
pre-incubated separately with luteolin, quercetin and baicalein
at different concentrations for 5 min at 37 C before the
addition of DNA. The inhibition of the enzyme by pre-
incubation with the compounds was compared with the
inhibitory effects of the compounds incubated simultaneously
withenzyme (LdTOP1LS) and supercoiledDNA inthe relaxa-
tion assay. Interestingly, under pre-incubation condition
luteolin, quercetin and baicalein showed  85–90% of enzyme
inhibition at 5, 15 and 3 mM concentrations, respectively
(Figure 1C) with IC50 values of 2.5, 5.5 and 1.5 mM,
respectively (Figure 1E), whereas under simultaneous condi-
tion similar inhibition was achieved at 20, 30 and 15 mMo f
luteolin, quercetin and baicalein, respectively (Figure 1B),
with IC50 values of 14, 17 and 9 mM, respectively
(Figure 1D). But CPT does not show any enhanced rate of
inhibition when pre-incubated with the enzyme (compare lane
20 of Figure 1C with lane 18 of Figure 1B). Thus the ﬂavones
probably interact with the enzyme (LdTOP1LS) and enhance
the inhibitory effect in relaxation reaction.
Flavones stabilize topoisomerase I–DNA complexes
In order to investigate the mechanism of inhibition of
topoisomerase I of L.donovani by these ﬂavones, trans-
esteriﬁcation was examined under equilibrium condition by
reacting LdTOP1LS with 25mer duplex oligonucleotide in the
presence of 60 mM baicalein, luteolin and quercetin. The
cleavage experiment was carried out with 50-
32P-end labeled
25mer duplex oligonucleotide containing a topoisomerase IB
speciﬁc binding motif as described in Materials and Methods.
Baicalein, luteolin and quercetin enhanced cleavage by
 30–36% with respect to the extent of cleavable complex
formed without the drug (Figure 2A, compare lane 2 with
lane 5). These results indicate that these selected ﬂavones
stabilize the covalent complex formed between 25mer duplex
DNA and LdTOP1LS, and correlate with the reduction of
relaxation activity in the presence of the ﬂavones.
To investigate the rate of stabilization of cleavable complexes
by baicalein, luteolin and quercetin we compared it with that of
CPT. Time course cleavage experiments were performed in a
standard assay mixture where the 50-
32P-end labeled 25mer
duplex oligonucleotide and the enzyme (LdTOP1LS) were
mixed at a molar ratio of 1:20 in the presence of the drugs.
The stabilization of cleavable complexes was determined by the
percentage of substrate converted to products and was plotted as
a function of time (6). With baicalein and luteolin,  60% of the
input DNA was cleaved and become covalently bound to the
protein.The reaction reached its cleavageplateauafter 60min of
incubation, whereas CPT completed the reaction after 35 min of
incubation producing 70% of the cleavage product. Quercetin
shows a reduced rate of stabilization of cleavable complex and
reached the cleavage plateau approximately after 90 min
(Figure 2B). This observation indicates that the rates of
stabilization of cleavable complex by the ﬂavones were  2-
to 3-fold reduced compared with that of CPT.
Flavones stabilize in vivo DNA–protein complexes
In T.brucei, T.cruzi and L.donovani, CPT promotes protein–
DNA complex formation with nuclear as well as kinetoplast
DNA (14). The ability of baicalein and other related ﬂavones
to induce covalent complexes of topoisomerases and DNA in
the L.donovani promastigotes were quantiﬁed by KCl-SDS
precipitation assay (29). Experiments were performed with
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3H]thymidine labeled promastigotes, treated with different
concentrationsofbaicalein,luteolin,quercetinandcamptothecin.
The data are summarized in Figure 3. Treatment of the
cells with 10, 50, 100, 150 and 200 mM of baicalein, luteolin
and quercetin for 5 h signiﬁcantly increase the SDS-K
+
precipitable complex compared with the untreated control
cells (Figure 3). The extent of SDS-K
+ precipitable complex
was similar to that obtained by 150 mM of CPT for 5 h
Figure 1. Inhibition of L.donovani topoisomerase I activity by flavones. (A) Structure of the flavones. (B) Relaxation of supercoiled pBS (SK
+) DNA with
reconstituted LdTOP1LS at a molar ratio of 3:1. Lane 1, 90 fmol of pBS (SK
+) DNA; lanes 2 and 16, same as lane 1, but simultaneously incubated with 30 fmol of
LdTOP1LS; lane 3, same as lane 2, but with 4% DMSO, respectively. Lanes 4–15 and 17–20, same as lane 2 and 16, but in the presence of 10, 15, 20 and 30 mMo f
luteolin,quercetin,baicaleinandCPTsimultaneouslyincubatedwithpBS(SK
+)DNAandLdTOP1LSat37 Cfor15min.(C)Pre-incubationofLdTOP1LSwiththe
selected flavones and CPT followed by addition of DNA. Lane 1, 90 fmol of pBS (SK
+) DNA; lanes 2, 3 and 16, same as lane 1 but DNA was added after pre-
incubation of 30 fmol LdTOP1LS with reaction buffer and with 4% DMSO, respectively, for 5 min at 37 C. Lanes 4–15 and 17–20 same as lane 2 and 16, but the
enzymewaspre-incubatedwith1,3,5and15mMofluteolin,quercetin,baicaleinandCPT,respectively,asindicated.ReactionswerestoppedbyadditionofSDStoa
final concentration of 0.5% (w/v)and were electrophoresed in 1% agarose gel. Positionsof supercoiled monomer(SM), relaxed and nickedmonomer(RL/NM)are
indicated.(D)Quantitativerepresentationofenzymeinhibitioninthepresenceofflavonesinrelaxationexperiments.LdTOP1LS(100fmol)wasincubatedwith1,5,
10,15,20,25,30mMconcentrationsofbaicalein,luteolinandquercetinsimultaneouslywithpBS(SK
+)DNAfor15minat37 C.(E)LdTOP1LSwaspre-incubated
separatelywith0.5,1,2,3,5,10,15mMconcentrationsofbaicalein,luteolinandquercetinfor5minat37 CinrelaxationbufferfollowedbyadditionofpBS(SK
+)
DNAandfurtherincubatedfor15minat37 C.Reactionswerestoppedandelectrophoresedasdescribedabove.Thepercentageofrelaxationinhibitionisplottedasa
functionofdrugconcentrationsasindicated.Alltheexperimentswereperformedthreetimesandrepresentativedatafromonesetoftheseexperimentsareexpressed
as means ± SD. Variations among different set of experiments were <5%.
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and a catalytic inhibitor of both topoisomerases I and II that
antagonizes CPT-induced cleavage (24), did not induce the
formation of SDS-K
+ precipitable complex, when L.donovani
cells were incubated for 3 h with the compound (Figure 3).
To prove that the SDS-K
+ precipitable complexes induced by
the selected ﬂavones are due to topoisomerase–DNA links, the
cells were pretreated with DHBA before incubation with
baicalein. The SDS-K
+ precipitable complex formation
induced by baicalein was clearly decreased when the cells
were pretreated with 150 mM DHBA. These results establish
that the SDS-K
+ precipitable complex is due to the formation
of covalent complexes between topoisomerases and DNA and
notduetoanyotherproteincross-linkedtoDNA.Thus,wecan
surmise that stabilization of LdTOP1LS-mediated duplex
oligonucleotide DNA cleavage with baicalein, luteolin and
quercetin correlates with the protein-linked DNA breaks in
L.donovani promastigotes and drug-induced cytotoxicity.
Selected flavones are acting reversibly against the
enzyme
The selected ﬂavones (baicalein, luteolin and quercetin) are
potent inhibitors of LdTOP1LS. Pre-incubation experiments
suggest that the compounds interact with the enzyme
(Figure 1C), but it is not clear whether these compounds are
acting reversibly or irreversibly against theenzyme. This critical
matter has been sorted out by dilution experiment. Reconstituted
LdTOP1LS was pre-incubated with3,5and15 mMo fb a i c a l e i n ,
luteolin and quercetin, respectively (Figure 4A, lanes 4–6), the
concentration at which 85–90% inhibitions is achieved, before
the addition of DNA. The reaction mixtures were subsequently
diluted 10-fold so the ﬁnal drugs concentrations become 0.3, 0.5
and 1.5 mM of baicalein, luteolin and quercetin, respectively.
Dilution study shows complete relief of inhibition (Figure 4A,
lanes 7–9). Drug-control reaction, i.e. inhibition study with 0.3,
0.5 and 1.5 mM of the respective drugs, showed the expected
pattern of inhibition (Figure 4A, lanes 10–12). Thus, the relief of
inhibition on dilution suggests that the selected ﬂavones are
acting reversibly against topoisomerase I.
Figure2.ComparisonsoftopoisomeraseI-mediatedDNAcleavageinducedby
flavonesandCPT.(A)Cleavagereactionsandelectrophoresisinadenaturating
polyacrylamide gel were performed as described in Materials and Methods.
Lane1,10nMof50-
32P-endlabeled25merduplexoligonucleotidesasindicated
above. Lane 2, same as lane 1, but incubated with 0.2 mM of LdTOP1LS in the
absence of inhibitors. Lanes 3–6, same as lane 2, but incubated with 60 mM
of quercetin, luteolin, baicalein and CPT, respectively, for 60 min at 23 C.
Positions of uncleaved oligonucleotide (25mer) and the cleavage product
(12mer oligonucleotide complexed with residual topo I) are indicated. (B)
Percentage of cleavable complex with LdTOP1LS and 50-
32P-25mer duplex
oligonucleotide DNA substrate, incubated for 5, 10, 20, 30, 60, 90, 180 min at
23 C in cleavage buffer containing 60 mM of baicalein, luteolin, quercetin and
CPT separately. All the reactions were stopped by addition of SDS to a final
concentration of 2% (w/v). Samples were precipitated with ethanol, digested
with trypsin and analyzed by 12% denaturing polyacrylamide gel as described
in Materials and Methods. The percentage of cleaved DNA substrate was
plotted as a function of time. The results depicted were performed three times
and representative data from one set of these experiments are expressed as
means ± SD. Variations among different set of experiments were <6%.
Figure 3. Analysis of drug induced covalent topoisomerase I–DNA complex
formation in L.donovani promastigotes by KCl-SDS precipitation assay.
Exponentially growing L.donovani promastigotes (5 · 10
6 cells /ml) were
labeled with [
3H]thymidine at 22 C for 24 h and then treated with different
concentrationsofdrugsasindicated.Partsofthelabeledcellsweretreatedwith
DHBA (150 mM) for 10 min before the addition of different concentration of
baicalein as indicated. SDS-K
+ precipitable complex were measured as
described in Materials and Methods. Experiments were performed three times
and representative data from one set of experiments are expressed as
means ± SD. Variations among different set of experiments were <6%.
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binding of luteolin, baicalein and quercetin to the enzyme
(LdTOP1LS). Addition of enzyme to luteolin led to an
increase in the ﬂuorescence intensity with slight shift in the
ﬂuorescence maxima (lmax) from 525 to 520 nm (Figure 4B,
panel a). A plot of fractional ﬂuorescence intensity as a function
of inverse topoisomerase concentrations is shown in Figure 4B
(panel b). A plot of DF/DFmax versus concentration of
LdTOP1LS was found to be hyperbolic, indicating the formation
of a drug–protein complex (Figure 4B, panel c). The dissociation
constant (Kd) calculated from the double reciprocal plot
using Equation 1 for luteolin-LdTOP1LS is 4.6 · 10
 5 M.
The dissociation constant for baicalein and quercetin were
also calculated and were 6.5 · 10
 5 M and 5.2 · 10
 5 M,
respectively.Theseresultsprovidethatthebindingsiteofluteolin
is located in the hydrophobic region of the protein, because the
shift of the lmax to the shot wave length means the ﬂuoropohore
was located in the hydrophobic environment (30). Thus, the
ﬂuorescence titration data reveal that these selected ﬂavones
interact with free enzyme and perhaps explain for stronger
inhibition in the enzyme–drug pre-incubation experiments.
Analysis of flavones–DNA interaction
In order to investigate the interaction of baicalein and quer-
cetin with DNA we used ﬂorescence titration with CT DNA.
Free baicalein when excited at 364 nm has a ﬂuorescence
emission maximum at 540 nm. Addition of CT DNA causes
slight shift of maximum peak from 540 to 537.6 nm
(Figure 5A). A progressive change in the ﬂuorescence spectra
of baicalein on addition of different concentrations of DNA
indicates an association between them. The dissociation
constant (Kd) calculated from the values using Scatchard
analysis (31) for baicalein is 3 · 10
-5 M. The Kd of
quercetin–DNA complex was calculated as described above
and is 4.8 · 10
 5 M.
Many chemical compounds that alter the gross structure
of DNA either by intercalation or by minor groove binding
have dramatic effect on the activity of topoisomerase I (32).
Our ﬂuorescence titration data reveal that ﬂavones interact
with the substrate DNA. Therefore, it is possible that ﬂavones
inhibit topoisomerase I by one of the two mechanisms.
Two approaches were followed to answer this question.
First, the ability of the ﬂavones to intercalate into DNA was
determined by topoisomerase I-catalyzed unwinding assay
(Figure 5B), which is based on the ability of intercalating com-
pounds to unwind the DNA duplex and thereby change the DNA
twist (22,26,27). The relaxed DNA was prepared as described in
Materials and Methods. Brieﬂy, the supercoiled pBluescript
(SK
+) DNA was treated with excess of topoisomerase I so
that no supercoiled DNA was left in the reaction mixture. The
DNA substrate was puriﬁed topological isomers of pBluescript
(SK
+) DNA and used as substrate for unwinding assay. In the
presence of strong intercalative drug such as m-AMSA, a net
negative supercoiling of the relaxed substrate DNA was induced
at 50 and 300 mM concentration (Figure 5B, lanes 3 and 4).
Conversely, no unwinding was observed with non-intercalative
drug etoposide at 50 and 300 mM concentrations (Figure 5B,
lanes5and6).Baicalein,luteolinandquercetinat50and100 mM
concentrations had no effect on the topological state of the DNA
(Figure 5B, lanes 7, 8, 10, 11 and lanes 13 and 14, respectively).
However, at 300 mM concentration luteolin, quercetin and bai-
calein induce negative supercoiling like m-AMSA (Figure 5B,
lanes 9, 12 and 15, respectively). Thus, the selected ﬂavones
intercalate into DNA at very high concentration, which is way
beyond the inhibitory concentration for the recombinant
L.donovani topoisomerase I.
Second, the ability of the selected ﬂavones to displace EtBr
from DNA was determined by a ﬂuorescence emission assay.
The DNA-bound form of ethidium has a signiﬁcantly stronger
ﬂuorescence emission than does ethidium; thus, displacement
Figure 4. Analysis of flavones-LdTOP1LS interaction (A) Lane 1, 50 fmol of
pBS(SK
+)DNA.Lane2,LdTOP1LS(100fmol)incubatedat37 Cfor5minin
thereactionmixturebeforeadditionofpBS(SK
+)DNA;lane3,sameaslane2.
Lanes 4–6, same as lane 2 but in the presence of 3, 5 and 15 mM of baicalein,
luteolinandquercetin,respectively,pre-incubatedwithLdTOP1LSfor5minat
37 C in relaxation buffer followed by addition of 50 fmol of pBS (SK
+) DNA
and further incubated for 10 min at 37 C. Lanes 7–9, same as lanes 4–6 but
diluted10-foldsothatthefinaldrugconcentrationsbecame0.3,0.5and1.5mM
of baicalein, luteolin and quercetin, respectively. These were followed by
addition of pBS (SK
+) DNA and further incubated for 10 min at 37 C. Lanes
10–12, same as lane 2 but the enzyme was pre-incubated with 0.3, 0.5 and
1.5 mM of baicalein, luteolin and quercetin before addition of DNA. (B) Fluor-
escence study of luteolin–enzyme interaction. (a) Fluorescence emission spec-
tra (lexcitation ¼ 380 nm) of 50 mM luteolin were determined as a function of
topoisomerase I (LdTOP1LS) concentration in the range of 0–20 mM. Control
fluorescence spectrum of LdTOP1LS is shown. Arrow indicates the change in
the emission spectra of luteolin on addition of LdTOP1LS. (b) Shows a plot of
the fractional fluorescence intensitiesof luteolin as a function of inverse topoi-
somerase I concentration. (c) A plot of DF/DFmax versus increasing concentra-
tion of LdTOP1LS.
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ﬂuorescence signal (28). Moreover, since EtBr intercalates to
minor groove of DNA, the assay is capable of detecting drugs
that either intercalate or bind in the minor groove of the DNA.
As shown in Figure 5C, the intercalative drug m-AMSA at
50 mM concentration readily dislodged the bound ﬂuorophore,
whereas non-intercalative drug etoposide was unable to do so.
Quercetin and luteolin, the weak intercalators, cause  6%
displacements at a concentration of 300 mM. Similarly,
baicalein displaces 4.6% at that concentration (Figure 5C).
Taken together, these data indicate that though the selected
ﬂavones intercalate into DNA at high concentrations, they do
not bind to the minor groove of DNA. Moreover, this high
concentration (300 mM) compared with the very low IC50 (2.5,
5.5, 1.5 mM for luteolin, quercetin and baicalein) of
topoisomerase I inhibition for the selected ﬂavones suggests
that the mode of inhibition is something different from
ﬂavone–DNA interaction.
Effect of flavones on single turnover cleavage and
religation activity
Catalytic assays do not allow a precise chronological
dissection of the inhibitory mechanism in relation to the
catalytic cycle. Thus, the step at which an inhibitor needs
to enter the catalytic cycle, and the step at which it becomes
effective in trapping or inhibiting the enzyme cannot be
differentiated. In order to overcome this problem, we have
made the oligonucleotide suicide substrate of topoisomerase
IB, which restricts the enzyme to a single round of cleavage
and religation and allows for addressing the two half-reactions
separately as we have described previously (6).
The substrate consisted of 50-
32P-labeled 14 bp duplex with
a 11 base 30 tail (6). Upon cleavage and formation of covalent
protein–DNA complex the AG dinucleotide at the 30 end of the
scissile strand is released. Suicidal cleavage assay was
performed in the presence and absence of baicalein, luteolin,
quercetin and CPT at 23 C for indicated time periods as
described in Materials and Methods. Religation was studied
under single turnover conditions by assaying the ability of the
covalent intermediate to attach a 50-hydroxyl-terminated
11mer to the covalently cleaved 12mer to form a 23mer
product (6). CPT stabilizes the suicide cleavage complex
with topoisomerase I of L.donovani and inhibits the religation
step (Figure 6A, lane 3) which are in keeping with that of
monomeric type IB topoisomerase (8.9). Similarly, baicalein,
luteolin and quercetin also inhibit the religation step when
added simultaneously with the enzyme and DNA in the
suicidal cleavage assay (Figure 6A, lanes 4–6) like CPT.
The rate of religation activity by LdTOP1LS in the presence
of CPT, baicalein, luteolin and quercetin was plotted as a
function of time (Figure 6B). The results indicated that
religation kinetics for LdTOP1LS was relatively faster in
the absence of the drugs while in the presence of ﬂavones
and CPT the time required to complete religation for
LdTOP1LS is increased  15- to 20 fold, indicating that
the ﬂavones stabilize the suicide enzyme–DNA covalent
complex and inhibit the religation reaction. On the contrary,
DHBA, a catalytic inhibitor of topoisomerase I, inhibits
the suicidal cleavage reaction (Figure 6A, lane 7). However,
when DHBA was pre-incubated for 5 min with the enzyme
Figure 5. Study of flavone–DNA interaction. (A) A change in the emission
spectra (lexcitation ¼ 364 nm) of 50 mM baicalein was determined as a function
of CT DNA concentration in the range of 0–0.22 mM. Arrow indicates the
change in the emission spectra of baicalein on addition of CT DNA. Control
fluorescencespectrumofCTDNAisindicated.(B)Flavones–DNAinteraction
as studied by agarose gel electrophoresis. Lane 2, relaxed pBS (SK
+) DNA
generated by treatment of pBS (SK
+) DNA (lane 1) with excess of topoisome-
rase I, followed by phenol–chloroform extraction and ethanol precipitation.
Lanes 3–6, same as lane 2, but incubated with 50 and 300 mMo fm-AMSA and
etoposide,respectively,asindicated.Lanes7–15,sameaslane2,butincubated
with 50, 100, 300 mM of baicalein, luteolin and quercetin as indicated. (C)
Fluorescence-based ethidium bromide displacement assay. Samples contained
1 mM of EtBr and 5 nM CT DNA. Increasing concentration (0–300 mM) of
baicalein,luteolin,quercetin,m-AMSAandetoposidewereaddedasindicated.
EtBr fluorescence was monitored with excitation wavelength at 510 nm and
emission at 590 nm.
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cidal substrate, the suicide-complex was completely inhibited
(Figure 6A, lane 8). In contrast to CPT, baicalein and luteolin
failed to inhibit the religation reaction, when added on the
enzyme substrate covalent complex that had been previously
formed in the absence of the drug, i.e. a condition where the
drugs and 11mer religation oligo were added together
(Figure 6A, lanes 9 and 10) after the suicidal cleavage
reaction. On the other hand, CPT could inhibit the religation
reaction under the same condition (Figure 6A, lane 11) or
when the drug is added simultaneously during suicidal
cleavage reaction (Figure 6A, lane 12). Although these
experiments do not exclude the existence of a drug ternary
complex(topoisomerase–DNAcomplexwithboundﬂavones),
we detected no effect of baicalein and luteolin on the stability
or strand transferase activity of the binary protein–DNA
complex. Taken together, these data suggest that interaction
of these ﬂavones with enzyme during trans-esteriﬁcation
reaction with DNA is a pre-requirement for the stabilization
of topoisomerase I-cleavable complex and subsequently
inhibiting the religation step.
Effect of baicalein and luteolin on the relaxation activity
of mutant L.donovani topoisomerase I
Our previous observation reveals that residues within 1 and 39
amino acids of the large subunit have signiﬁcant roles in
modulating CPT sensitivity (6). So to understand the possible
molecular interaction between the ﬂavones (baicalein and
luteolin) and the enzyme, we investigated the inhibitory effect
on the mutant enzyme (LdTOP1D39LS) in plasmid DNA
relaxation assay. Interestingly, we observed that baicalein
and luteolin show considerable inhibitionofrelaxationactivity
up to 60% at 30 mM concentration (Figure 7A, lanes 8 and 9)
compared with that of CPT, where no inhibition of relaxation
activity was observed (Figure 4A, lane 5).
SelectedflavonesinducetopoisomeraseI-mediatedDNA
cleavage in the presence of CPT-resistant
topoisomerase I enzyme
We investigated the interaction of baicalein and luteolin with
CPT-resistant mutant enzyme (LdTOP1D39LS) in the
equilibrium cleavage assay. We have described earlier that
with LdTOP1D39LS, CPT-induced stabilization of cleavable
complex reduced to 6-fold compared with the wild-type
enzyme (6). Figure 7B shows that the DNA cleavage efﬁciency
of LdTOP1D39LS in the presence of CPT is same as in the
absence of CPT (Figure 7B, compare lanes 2 and 3), while with
baicaleinandluteolin,cleavageefﬁciencyofthemutantenzyme
increasedto 35%(Figure7B,lanes 4and 5). This result indicates
thattheresidues(1–39aminoacidsofthelargesubunit)although
important in modulating bi-subunit topoisomerase I activity
in vitro are not critical for baicalein-induced topoisomerase I-
mediated DNA cleavage.
To further establish the in vivo effect of the selected ﬂavones
on CPT-resistant topoisomerase I, we selected a single highly
resistant L.donovani strain (Ld160CPT
R)a sd e s c r i b e db y
Marquis et al. (15). It was previously described that highly
resistant L.donovani strain (LdRCPT.160) developed by
stepwise exposure to CPT induces point mutations (Gly 185
Arg and Asp325 Glu) in the large subunit (LdTOP1L) of the
Figure 6. Effect of flavones on single turnover cleavage and religation. (A)
Suicidal cleavage assay was performed with the 50-
32P-end labeled suicide
DNA substrate (14mer/25mer) as indicated. The DNA substrate was incubated
withLdTOP1LSinthepresenceorabsenceofinhibitorsat23 Casdescribedin
Materials and Methods. Active cleavage complexes containing LdTOP1LS
attached to the covalently cleaved 12mer of the suicide substrate were reacted
with50-hydroxyl-terminated11mertoforma23merproductfor10minat37 C
and the products were analyzed in a denaturating polyacrylamide gel. Lane 1,
suicide DNA substrate only; lane 2 same as lane 1, but in the presence of
LdTOP1LS and 50-hydroxyl-terminated 11mer religation oligonucleotides.
Lanes 3 and 12, same as lane 2, but incubated with 50 mM CPT. Lanes 4–6,
same as lane 2, but with 50 mM baicalein, luteolin and quercetin added simul-
taneouslywiththeenzymeandDNAinthesuicidalcleavageassay;lane7,same
as lane 2, but with 50 mM DHBA pre-incubated for 2 min at 23 C with the
enzymebeforetheadditionofDNAinthesuicidalcleavageassay.Lane8,same
as lane 7, but followed by addition of 50 mM baicalein simultaneously in the
cleavage assay. Lanes 9–11, same as lane 2, but 50 mM baicalein, luteolin and
CPT were added after suicidal cleavage reaction (on enzyme–substrate com-
plex) together with 11mer religation oligo. All the reactions were stopped by
additionofSDStoafinalconcentrationof2%(w/v).Sampleswereprecipitated
with ethanol, digested with trypsin and analyzed by denaturating polyacryla-
mide sequencing gel electrophoresis. The uncleaved suicidal oligonucleotide,
covalent complex and the religation products are indicated. (B) Religation
activity of LdTOP1LS in the presence of inhibitors as indicated in the figure.
Active cleavage complexes containing LdTOP1LS covalently attached to
thecleaved12merofthesuicidesubstratewerereactedwith50-hydroxyl-termi-
nated11mertoforma23merproduct.Thereactionswerecarriedoutfor1,5,10,
15,20and30minat37 Candtheproductswereanalyzedasabove.Therelative
amountofcleavageproductsconvertedtoligationproductsineachsamplewere
plottedasfunctionoftime.Theresultsdepictedwereperformedthreetimesand
representative data from one set of these experiments are expressed as
means ± SD. Variations among different set of experiments were <5%.
Nucleic Acids Research, 2006, Vol. 34, No. 4 1129bi-subunit topoisomerase I (15). Relaxation assays performed
with nuclear extract prepared from Ld160CPT
R cells show
reduced fold of activity of the mutant enzyme and sensitivity
toward CPT compared with the wild-type endogenous enzyme.
Moreover, nuclear extract prepared from CPT-resistant cell
(Ld160CPT
R) shows inhibition of topoisomerase I activity
by baicalein and luteolin (data not shown). In order to ﬁnd
out whether the selected ﬂavones could also stabilize covalent
complexes of topoisomerase I and DNA inside the CPT-
resistant cell (Ld160CPT
R), we carried out KCl-SDS copreci-
pitation assay as described above. The KCl-SDS precipitation
assays in CPT-resistant cells are summarized in Figure 7C.
Baicalein and luteolin were the most effective compounds
that signiﬁcantly increase the SDS-K
+ precipitable complex
compared with the untreated control cells when applied to
the medium at 200 mM concentration for 5 h (Figure 7C).
However, treatment of the CPT-resistant cell (Ld160CPT
R)
with 200 mM CPT for 5 h did not induce the formation of
SDS-K
+ precipitable complex (Figure 7C). Thus, our results
suggest that baicalein and luteolin can inhibit CPT-resistant
mutant enzyme and favor the interpretation that the binding
site of CPT may be partially overlapping or different from
that of the selected ﬂavones.
DISCUSSION
Crystal structure of human topoisomerase I seems compatible
with a rotational model for the relief of supercoils during DNA
relaxation. Modeling studies indicated that the DNA would
likely contact with both the CAP and linker regions of the
protein during strand rotation (33). Thus, it appears that the
CAP and catalytic domain of human topoisomerase I undergo
a conformational change after cleavage to accommodate DNA
rotation (33,34).
But interestingly, L.donovani topoisomerase I is an unusual
bi-subunit enzyme where the core DNA binding domain and
the catalytic domain harboring the consensus SKXXY motif
lie in separate subunits (4,5). Our recent ﬁndings reveal that
1–39 amino acid residues of the large subunitthat resemble the
CAPregionofthemonomericenzymes haveamodulatingrole
in non-covalent interaction with DNA and sensitivity toward
CPT (6). Thus, the N-terminal of the bi-subunit enzyme has an
important role in strand rotation and DNA relaxation. The
linker domain, which is poorly conserved and variable in
length, links the core and catalytic domain of the monomeric
enzyme and is responsible for the processivity of the enzyme
(35). However, the functional linker is absent in L.donovani
enzyme that perhaps account for the reduced processivity and
Figure 7. Effect of baicalein and luteolin on CPT-resistant L.donovani topoi-
somerase I. (A) Plasmid DNA relaxation experiments were performed with
LdTOP1D39LS separately in the presence of CPT, baicalein and luteolin as
indicated. Plasmid DNA and reconstituted mutant enzyme LdTOP1D39LS
were mixed at a molar ratio of 1:2. Lane 1, 60 fmol of pBS (SK
+) DNA;
lane 2, same as lane 1, but incubated with 120 fmol LdTOP1D39LS in the
absence of inhibitors; lanes 3–10, same as lane 2, but incubated with different
concentrations of CPT, baicalein and luteolin at 37 C for 10 min. All reactions
were stopped by addition of SDS to a final concentration of 0.5% (w/v) and
were electrophoresed in 1% agarose gel. Positions of supercoiled monomer
(SM),relaxedandnickedmonomer(RL/NM)andlinearDNA(L)areindicated.
(B) Stabilization of cleavable complex with CPT-resistant enzyme
(LdTOP1D39LS) in the presence of baicalein and luteolin. Lane 1, 10 nM
of50-
32P-endlabeled25merduplexoligonucleotidesasindicated.Lane2,same
aslane1, butincubatedwithequalamount(0.2mM)ofLdTOP1D39LS;lane3,
sameaslane2,butincubatedinthepresenceof60mMCPT;lanes4and5,same
as lane 2, but in the presence of 60 mM of baicalein and luteolin, respectively,
incubated for 60 min at 23 C. Positions of uncleaved oligonucleotide (25mer)
andthecleavageproduct(12meroligonucleotidecomplexedwithresidualtopo
I) are indicated. (C) Topoisomerase I–DNA linkage analysis in CPT-resistant
L.donovani promastigotes (Ld160CPT
R) by KCl-SDS precipitation assay.
CPT-resistant L.donovani promastigotes (5 · 10
6 cells/ml) were labeled as
described in Materials and Methods. The labeled cells were treated with
different concentrations of CPT, luteolin and baicalein as indicated. SDS-K
+
precipitable complexes were measured as described in Materials and Methods.
The experiments were performed three times and representative data from one
setoftheseexperimentsareexpressedasmeans ± SD.Variationsamongdifferent
set of experiments was <5%.
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topoisomerase I (5).
CPT, an important class of antitumor agent (7), is an uncom-
petitive inhibitor that directly traps the enzyme–DNA covalent
complexand slows thereligation step ofthenicking closing cycle
(8,9). CPT also hinders or blocks DNA rotation, which is evi-
denced by the crystal structure of the ternary complex between
human topoisomerase I (topo 70) covalently linked to the DNA
and the CPT derivative topotecan (11). If rotation is severely
impeded by the bound CPT such that little or no rotation occurs
during some nicking closing cycle, then the rate of DNA relaxa-
tion would reduce (35). This hypothesis corresponds well with
our observation that CPT inhibits L.donovani topoisomerase I
activity by  15-fold at low salt concentration (6). Recent ﬁnding
reveals that a highly CPT-resistant L.donovani strain
(LdRCPT.160) developed by stepwise exposure to CPT induces
point mutations (Gly 185 Arg and Asp325 Glu) in the large
subunit (LdTOP1L) of the bi-subunit topoisomerase I. The
mutant enzyme shows reduced activity as well as reduced sensi-
tivity toward CPT (15).
Flavones are also potent inhibitors of topoisomerase II and
monomeric topoisomerase I (19,22,27,36–38). Recently, we
have described that luteolin inhibitsL.donovani topoisomerase
II by interfering with the ATPase activity (38). Flavones have
also been described as inhibitors of hexameric replicative
helicases RepA and interfere with the ATPase and double-
stranded DNA-unwinding activity of the enzyme (39). In this
study, we have tried to gain insight into the molecular
mechanism of inhibition of unusual bi-subunit topoisomerase
I with luteolin (5,7,30,40-tetrahydroxy ﬂavone), quercetin
(3,5,7,30,40-pentahydroxy ﬂavone) and baicalein (5,6,7
trihydroxy ﬂavone) and compare it with CPT. Baicalein,
luteolin and quercetin are potent inhibitors of recombinant
L.donovani bi-subunit topoisomerase I like CPT in the plasmid
DNA relaxation assay, but in contrast to CPT, ﬂavones bind
with the free enzyme. Interaction of luteolin, baicalein and
quercetin with the free enzyme was indicated by the following
two experiments: (i) pre-incubation of the enzyme with the
ﬂavones before addition of DNA in relaxation assay (Figure 1C)
and (ii) ﬂorescence titration of the ﬂavones with increasing
concentration of the enzyme (Figure 4). This observation is
consistent with the monomeric topoisomerase I and RepA inter-
acting with the ﬂavones (27,38,39). However, the L.donovani
topoisomerase I–ﬂavone interaction was reversible, as studied
by dilution experiments.
Baicalein, luteolin and quercetin are planer aromatic
ﬂavones that could bind DNA by intercalation due to the
presence of the double bond between the 2 and 3 carbon of
the C-ring (37). Direct measurement of this interaction made
by ﬂuorescence spectroscopy reveals Kd values of baicalein-
DNA of 3 · 10
 5 M, quercetin–DNA of 4.8 · 10
 5 M and
luteolin-DNA of 4.6 · 10
 5 M (27). These values are
comparable with the Kd values of topoisomerase II poisons
m-AMSA-DNA of 2.1 · 10
 5 M (40) and etoposide-DNA of
5.8 · 10
 5 M (41). The ﬂavones–DNA interactions are
much weaker than EtBr binding to DNA (4 · 10
 7 M)
(42). We have addressed this issue by two independent experi-
ments. EtBr displacement assay reveals that the selected ﬂa-
vones intercalate with DNA at high concentrations (300 mM)
and do not bind to the minor groove of DNA. This observation
is further supported by DNA-unwinding assay. However,
baicalein, luteolin and quercetin completely inhibit
L.donovani topoisomerase I at 3, 5 and 15 mM concentrations,
respectively, when the enzyme is pre-incubated with the
compounds. Thus, it becomes evident that inhibition of
relaxation by ﬂavones is not due to intercalation with DNA.
Instead, it is more likely that the compounds exert their effects
by speciﬁc interactions with the enzyme or with the enzyme–
DNA binary complex.
A topoisomerase reaction has three general mechanistic steps,
i.e. (i) binding of the enzyme to the substrate DNA, (ii) cleavage
by trans-esteriﬁcation reaction and subsequent strand passage
through the break leading to the change in the linking number
and (iii) strand religation. Investigation on the kinetics of stabi-
lization of cleavage complex (step ii) reveals that the rate of
stabilization of cleavable complex by the ﬂavones were  2-
to 3-fold reduced compared with that of CPT. KCl-SDS preci-
pitation assay reveals that the selected ﬂavones stabilize in vivo
covalent topoisomerase I–DNA complex in L.donovani promas-
tigote cells (Figure 3) and is consistent with the observation in
mammalian HL-60 cells (36). Thus, with the stabilization of
cleavage complex the ﬂavones inhibit the subsequent religation
reaction (step iii) like CPT, as we observed in single turnover
condition(Figure6).Flavonesinhibitreligationreactionupto15-
fold compared with the religation property of the wild-type
enzyme. However, in contrast to CPT, baicalein and luteolin
failed to inhibit the religation step when the drugs were added
to pre-formed enzyme substrate cleavable complex (Figure 6).
Thus, we can surmise that although the mechanism of inhibition
of topoisomerase I by these selected ﬂavones and CPT are simi-
lar, the interaction of ﬂavones with enzyme during trans-ester-
iﬁcation reaction with DNA is a pre-requisite for stabilization of
cleavable complex.
This differential mechanism to induce the stabilization of
cleavable complexwith topoisomerase I and DNA by CPT and
the selected ﬂavones led us to investigate the effect of
baicalein and luteolin on CPT-resistant mutant enzyme
LdTOP1D39LS lacking 1–39 amino acids of the large subunit
(6). In duplex oligonucleotide cleavage assay with
LdTOP1D39LS, the DNA cleavage efﬁciency of CPT dropped
by 6-fold while that of baicalein was reduced by only 1.5-fold.
The results indicate that the residues within 1 and 39 amino
acid of the large subunit of bi-subunit topoisomerase I
although important in modulating topoisomerase I activity
and CPT sensitivity are not critical for baicalein-induced
topoisomerase I-mediated DNA cleavage. These observations
are in keeping with that of the stabilization of cleavable
complex formation between topoisomerase I and DNA inside
CPT-resistant cells (Ld160CPT
R). Thus, in the light of our
experiments one possibility could be that the interacting
amino acid residues of topoisomerase I may be partially
overlapping or different for the ﬂavones and CPT.
Our understanding of the interaction of L.donovani
topoisomerase I–DNA and the selected ﬂavones could be
enhanced immeasurably by crystal structure of the enzyme
bound to DNA and drugs, with the aim to synthesize better
inhibitors with higher speciﬁcity.
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